|
GLTSCR1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.573800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.003000E-01 |
| Normal-vs-Stage2 |
6.134800E-01 |
| Normal-vs-Stage3 |
1.297390E-01 |
| Normal-vs-Stage4 |
4.279600E-01 |
| Stage1-vs-Stage2 |
8.631800E-01 |
| Stage1-vs-Stage3 |
3.368400E-01 |
| Stage1-vs-Stage4 |
2.299800E-01 |
| Stage2-vs-Stage3 |
4.141200E-01 |
| Stage2-vs-Stage4 |
3.281800E-01 |
| Stage3-vs-Stage4 |
1.076650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.894000E-02 |
| Normal-vs-AfricanAmerican |
4.803200E-01 |
| Normal-vs-Asian |
3.635600E-01 |
| Caucasian-vs-AfricanAmerican |
4.238600E-01 |
| Caucasian-vs-Asian |
3.615600E-01 |
| AfricanAmerican-vs-Asian |
2.436400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.166200E-01 |
| Normal-vs-Female |
4.700000E-02 |
| Male-vs-Female |
3.180600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.038400E-01 |
| Normal-vs-Extreme_Weight |
2.443600E-01 |
| Normal-vs-Obese |
3.303600E-02 |
| Normal-vs-Extreme_Obese |
9.852400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.053600E-01 |
| Normal_Weight-vs-Obese |
1.655420E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.649000E-01 |
| Extreme_Weight-vs-Obese |
2.369400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.355000E-01 |
| Obese-vs-Extreme_Obese |
2.325200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.550100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.142100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.524400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.336600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.172400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.878300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.693800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.770400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.624200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.341200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.143800E-03 |
| Normal-VS-Type2 PRCC |
4.635800E-02 |
| Normal-VS-KIRP CIMP |
2.713400E-01 |
| Normal-VS-Unclassified PRCC |
5.739500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.32510036066469E-10 |
| Type1 PRCC-VS-KIRP CIMP |
6.167600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.515800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.609970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.86330000000656E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
7.789200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.510600E-01 |
| Normal-vs-N1 |
8.178200E-02 |
| Normal-vs-N2 |
6.527400E-01 |
| N0-vs-N1 |
2.251000E-01 |
| N0-vs-N2 |
8.953600E-01 |
| N1-vs-N2 |
6.472800E-01 |
|
|
